December 11th According to the Washington Post, the FDA’s coronavirus vaccine team recommended approval of Pfizer’s coronavirus vaccine.
On the 10th local time, the FDA’s COVID-19 vaccine team found that the benefits of using the Pfizer/BioNTech coronavirus vaccine for adults aged 16 and above outweigh the known risks, and the FDA’s coronavirus vaccine is small.
The group recommended approval of Pfizer’s coronavirus vaccine.
FDA Director Hahn said in an interview with the media earlier in the day that the Authority will make a decision quickly after the expert group makes recommendations.
The New York Times quoted people familiar with the agency’s plan as saying that the FDA is expected to pass the emergency use authorization on Saturday (12th).